Pfizer Inc. buy BMO Capital Markets
Start price
23.06.26
/
50%
€21.91
Target price
23.06.27
-
Performance (%)
3.72%
Price
06.08.26
€22.73
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 3.72%. This prediction currently runs until 23.06.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 5.208% | 5.208% |
| iShares Core DAX® | 1.842% | 1.387% |
| iShares Nasdaq 100 | 4.659% | -1.797% |
| iShares Nikkei 225® | 3.963% | -5.216% |
| iShares S&P 500 | 3.700% | 1.576% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (PFE) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for PFE provided by MarketBeat